Journal
The Journal of clinical endocrinology & metabolism
Publication Date
12-21-2023
Volume
109
Issue
1
First Page
25
Last Page
35
Document Type
Open Access Publication
DOI
10.1210/clinem/dgad637
Rights and Permissions
Raymond S Douglas, Steven Couch, Sara T Wester, Brian T Fowler, Catherine Y Liu, Prem S Subramanian, Rosa Tang, Quang T Nguyen, Robi N Maamari, Shoaib Ugradar, Kate Hsu, Michael Karon, Marius N Stan, Efficacy and Safety of Teprotumumab in Patients With Thyroid Eye Disease of Long Duration and Low Disease Activity, The Journal of Clinical Endocrinology & Metabolism, Volume 109, Issue 1, January 2024, Pages 25–35, https://doi.org/10.1210/clinem/dgad637. https://academic.oup.com/jcem/article/109/1/25/7334391?login=true. © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Recommended Citation
Douglas, Raymond S; Couch, Steven; Wester, Sara T; Fowler, Brian T; Liu, Catherine Y; Subramanian, Prem S; Tang, Rosa; Nguyen, Quang T; Maamari, Robi N; Ugradar, Shoaib; Hsu, Kate; Karon, Michael; and Stan, Marius N, "Efficacy and safety of teprotumumab in patients with thyroid eye disease of long duration and low disease activity." The Journal of clinical endocrinology & metabolism. 109, 1. 25 - 35. (2023).
https://digitalcommons.wustl.edu/oa_4/4696
Department
ICTS (Institute of Clinical and Translational Sciences)